CP404
/ Compellis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 25, 2021
The Effects of Combining Cancer Drugs with Compounds Isolated from Combretum zeyheri Sond. and Combretum platypetalum Welw. ex M.A. Lawson (Combretaceae) on the Viability of Jurkat T Cells and HL-60 Cells.
(PubMed, Biomed Res Int)
- "This study sought to evaluate the antiproliferative effects of compounds isolated from C. zeyheri and C. platypetalum on Jurkat T and HL-60 cancer cell lines in combination with doxorubicin and/or chlorambucil. Therefore, CP 404 (1), 3-O-β-L-rrhamnopyranosyl-5,7,3'4',5'-pentahydroxyflavone, has the potential to be a source of lead compounds that can be developed for anticancer therapy. Further structure-activity relationship studies on this compound are warranted."
Journal • Infectious Disease • Oncology • Respiratory Diseases • Tuberculosis
1 to 1
Of
1
Go to page
1